IP Library Granted Patent US 9,260,516
Granted Patent B2
US 9,260,516 · App. 12/296,193 · Granted Feb 16, 2016

Method for promoting muscle regeneration by administering an antibody to the IL-6 receptor

Inventors: Norihiro Nishimoto (Osaka, JP); Yoshinobu Ohira (Osaka, JP)
Assignee: Osaka University
C07K16/248A61K38/204C07K16/2866A61K2039/505
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,260,516
App. No.
12/296,193
Granted
Feb 16, 2016
Kind
B2
Abstract

The present inventors studied the effects of inhibiting the IL-6 signaling pathway on muscle cell growth. As a result, they discovered that, administering an IL-6 inhibitor can promote the adhesion, proliferation, and differentiation of satellite cells and therefore muscle regeneration.

Claims (10)

1. A method for promoting muscle regeneration in a subject affected with muscle atrophy, which comprises the steps of:

selecting a subject having muscle atrophy caused by an absence of gravitational loading or disuse muscle atrophy;

subsequently administering to the subject an effective amount of an IL-6 inhibitor antibody that binds to an IL-6 receptor, inhibits IL-6 from binding to the IL-6 receptor, and further inhibits the IL-6 signaling pathway; and

subsequently re-loading the subject's atrophied muscles for at least 7 days.

2. The method of claim 1 , wherein the antibody is a monoclonal antibody.

3. The method of claim 1 , wherein the antibody is an antibody that recognizes human IL-6 receptor.

4. The method of claim 1 , wherein the antibody is a recombinant antibody.

5. The method of claim 1 , wherein the antibody is a chimeric, humanized, or human antibody.

6. The method of claim 1 , wherein the antibody is MR16-1, PM-1, AUK12-20, AUK64-7, or AUK146-15.

7. The method of claim 1 , wherein the selecting step further comprises selecting a subject having muscle atrophy caused by a microgravity space environment, long-term bed rest, or a plaster cast-immobilized state.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2009
From: OHIRA, YOSHINOBU
To: OSAKA UNIVERSITY
Reel/Frame 022496/0427 →
Priority Claims (1)
JP 2006-106445 · Apr 7, 2006 · national
Continuity (1)
Related Publication 20100008907A1 · Jan 14, 2010